Weil Company’s Eli Lilly LLY Stock Holding History

Weil Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-85	Closed	-$10K	–	228
2019 Q3	$10K	Buy	+85	New	+$9.46K	0.01%	288

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Weil Company's LLY Position: Q4 2019 in Review

Weil Company sold out of Eli Lilly (LLY) in Q4 2019, closing a stake of 85 shares — an estimated $10K sold.

Weil Company first reported a position in LLY in Q3 2019 and held it in 1 quarter. The position peaked at $10K in Q3 2019. 1,673 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

Weil Company reported no remaining Eli Lilly position as of Q4 2019 after selling out during the quarter.
Weil Company sold 85 Eli Lilly shares in Q4 2019, an estimated $10K.
Weil Company first reported a position in Eli Lilly in Q3 2019 and held it in 1 quarter.
Weil Company's Eli Lilly position peaked at $10K in Q3 2019.
1,673 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.